Family cancer burden predicts risk in patients with inflammatory bowel disease
A study from Karolinska Institutet indicates that individuals with inflammatory bowel disease (IBD) are at a higher risk of developing colorectal cancer if they have multiple first-degree relatives with the disease. The findings suggest that family history should play a larger role in future cancer screening guidelines.
Why it matters
This research could lead to more personalized and effective cancer screening protocols for patients with chronic digestive conditions.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Pixabay/CC0 Public Domain People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely to develop the disease themselves. This is demonstrated by a new Swedish registry study from Karolinska Institutet, published in the journal Gastroenterology . The findings raise the question of whether future cancer screening guidelines should place greater emphasis on the number of cancer cases in a patient's family.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in